98 results on '"myelodysplasia"'
Search Results
2. Unveiling the clinical spectrum of relapsing polychondritis: insights into its pathogenesis, novel monogenic causes, and therapeutic strategies
3. The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
4. Increased medial pedicle angulation of the lumbar spine as a function of the posterior osseous defect in patients with myelomeningocele
5. NFĸB Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies
6. Copper Levels in Patients with Unexplained Dysplastic Cytopenia
7. Knochenmarkfibrose bei primärer Myelofibrose in Abhängigkeit von myelodysplasie- und altersassoziierten Mutationen der Hämatopoese
8. Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO
9. Increased 68 Ga-PSMA-11 Bone Marrow and Splenic Uptake in a Case of Erythroid Myelodysplasia
10. BOK promotes erythropoiesis in a mouse model of myelodysplastic syndrome
11. Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series
12. Impact of patient position on coronal Cobb angle measurement in non-ambulatory myelodysplastic patients
13. Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practice
14. Clinical, MRI, and histopathological findings of congenital focal diplomyelia at the level of L4 in a female crossbred calf
15. GATA2 mutation in long stand Mycobacterium kansasii infection, myelodysplasia and MonoMAC syndrome: a case-report
16. Improving Treatment for Myelodysplastic Syndromes Patients
17. Management of Neurogenic Bladder
18. The Osteoblastic Niche in Hematopoiesis and Hematological Myeloid Malignancies
19. Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients
20. Prior hypomethylating agent use lacks impact on clinical outcome in patients with secondary acute myeloid leukemia arising from myelodysplastic syndromes treated with standard induction chemotherapy
21. Bilateral Rib-Based Distraction to the Pelvis for the Management of Congenital Gibbus Deformity in the Growing Child With Myelodysplasia
22. Emerging Concepts in Transitional Care of Congenital Genitourinary Reconstructions
23. Zytopathologie in der Diagnostik hämatologischer Erkrankungen
24. Multilineage dysplasia is associated with a poorer prognosis in patients with de novo acute myeloid leukemia with intermediate-risk cytogenetics and wild-type NPM1
25. Transition of Care and Treatment of the Adult Spina Bifida Patient
26. Efficacy and tolerability of 5-day azacytidine dose-intensified regimen in higher-risk MDS
27. Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia
28. Prognostic implications of CD14 positivity in acute myeloid leukemia arising from myelodysplastic syndrome
29. Myelodysplasia and Malignancy-Associated Vasculitis
30. GATA-2 anomaly and clinical phenotype of a sporadic case of lymphedema, dendritic cell, monocyte, B- and NK-cell (DCML) deficiency, and myelodysplasia
31. Myelodysplasia presenting as thoracic spinal epidural extramedullary hematopoiesis: a rare treatable cause of spinal cord myelopathy
32. Short telomeres result in chromosomal instability in hematopoietic cells and precede malignant evolution in human aplastic anemia
33. Leukemia stem cells
34. Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT
35. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy
36. Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia
37. Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria
38. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
39. Neurogenic bladder: etiology and assessment
40. Allogeneic stem cell transplantation in Fanconi anemia patients presenting with myelodysplasia and/or clonal abnormality: update on the Saudi experience
41. Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40–CD40L interactions with T helper cells
42. Lineage-specific clonality analysis of chronic myeloproliferative disorders and myelodysplastic syndrome by human androgen receptor assay
43. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
44. Fehlbildungen des Rückenmarkes und ihre Differenzialdiagnose
45. A retrospective study of the incidence and classification of bone marrow disorder in cats (1996–2004)
46. Hämatologische Nebenwirkungen der Tyrosinkinaseinhibition mit Imatinib
47. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry
48. Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro
49. CD34+ marrow progenitors from MDS patients with high levels of intramedullary apoptosis have reduced expression of α4β1 and α5β1 integrins
50. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.